Simplex Trading’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-97,700
| Closed | -$20K | – | 9897 |
|
|
2025
Q2 | $20K | Buy |
97,700
+91,500
| +1,476% | +$546K | ﹤0.01% | 6777 |
|
|
2025
Q1 | $10K | Buy |
+6,200
| New | +$8.18K | ﹤0.01% | 7112 |
|
|
2024
Q4 | – | Sell |
-12,900
| Closed | -$20K | – | 9443 |
|
|
2024
Q3 | $20K | Sell |
12,900
-2,100
| -14% | -$3.47K | ﹤0.01% | 6682 |
|
|
2024
Q2 | $26K | Sell |
15,000
-1,700
| -10% | -$3.94K | ﹤0.01% | 6689 |
|
|
2024
Q1 | $48K | Buy |
+16,700
| New | +$27.2K | ﹤0.01% | 6301 |
|
|
2021
Q4 | – | Sell |
-1,940
| Closed | -$16K | – | 11287 |
|
|
2021
Q3 | $16K | Buy |
1,940
+330
| +20% | +$2.42K | ﹤0.01% | 8621 |
|
|
2021
Q2 | $13K | Buy |
1,610
+1,609
| +160,900% | +$18K | ﹤0.01% | 8927 |
|
|
2021
Q1 | $1K | Sell |
1
-4
| -80% | -$59 | ﹤0.01% | 8578 |
|
|
2020
Q4 | $7K | Buy |
+5
| New | +$37 | ﹤0.01% | 7602 |
|
|
2017
Q3 | – | Hold |
0
| – | -$1K | – | 6507 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$167 | – | 5700 |
|
|
2017
Q1 | $13K | Buy |
+1
| New | +$190 | ﹤0.01% | 3727 |
|
|
2016
Q3 | – | Hold |
0
| – | -$5K | – | 6353 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$716 | – | 4268 |
|
|
2016
Q1 | $10K | Buy |
+1
| New | +$796 | ﹤0.01% | 3471 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$1K | – | 4976 |
|
|
2015
Q3 | $6K | Sell |
1
-2
| -67% | -$2.05K | ﹤0.01% | 3864 |
|
|
2015
Q2 | $70K | Buy |
+3
| New | +$4.84K | 0.01% | 1427 |
|
|
2015
Q1 | – | Sell |
-1
| Closed | -$2.17K | – | 3135 |
|
|
2014
Q4 | $31K | Buy |
+1
| New | +$1.78K | ﹤0.01% | 1719 |
|
Simplex Trading's RGLS Position: Q3 2024 in Review
Simplex Trading sold out of Regulus Therapeutics (RGLS) in Q3 2024, closing a stake of 3,622 shares — an estimated $5.99K sold.
Simplex Trading first reported a position in RGLS in Q1 2015 and held it in 17 quarters. The position peaked at $362K in Q2 2015. 70 funds tracked by Wall St. Rank hold RGLS as of Q3 2024.
- Simplex Trading reported no remaining Regulus Therapeutics position as of Q3 2024 after selling out during the quarter.
- Simplex Trading sold 3,622 Regulus Therapeutics shares in Q3 2024, an estimated $5.99K.
- Simplex Trading first reported a position in Regulus Therapeutics in Q1 2015 and held it in 17 quarters.
- Simplex Trading's Regulus Therapeutics position peaked at $362K in Q2 2015.
- 70 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2024.
Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.